July 28 (Reuters) – Lepu Biopharma Co Ltd: * REPORTS POSITIVE TOP-LINE RESULTS FROM GLOBAL PHASE III TRIAL OF CMG901 (AZD0901) Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)